GlassScriptPhysician profile
Rod J Turner
NPI 1497101471
$5,221.47
in general payments reported to CMS, 2019-2025
8 companies · $84.64 in 2025
The $84.64 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.49 · 2022: $37.02 · 2023: $4,850 · 2024: $214 · 2025: $84.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $648.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $4,500.00 | 2023 | Exparel, Iovera, Zilretta |
| Depuy Synthes Sales INC. | $211.56 | 2022-2025 | Monovisc, Orthovisc |
| Miach Orthopaedics, INC. | $210.36 | 2023 | |
| Medical Device Business Services, INC. | $123.56 | 2024 | Peak, Monovisc, Orthovisc |
| Kowa Pharmaceuticals America, INC. | $118.98 | 2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $21.52 | 2025 | |
| Pfizer INC. | $19.33 | 2021 | |
| Hydrocision, INC. | $16.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rod Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.